Third Wave Technologies, Inc.
Third Wave Technologies is riding the biotech breakers. Using its Invader technology, Third Wave develops molecular diagnostic tests that detect genetic variations associated with a variety of conditions, including cystic fibrosis, cardiovascular risk factors, and infectious disease. Some tests can determine a patient's likely response to certain drugs, making it possible for doctors to avoid prescribing a drug that might cause dangerous side effects. Third Wave company has a strong presence in Japan, where it has a collaboration agreement with genetic researchers at the University of Tokyo. Third Wave Technologies was acquired by Hologic in 2008 for $580 million.
Contact Details
Office Address
Third Wave Technologies, Inc.
502 S. Rosa Road
53719, WI, USA Madison
Phone: (608) 273-8933
Fax: (608) 273-8618
Executives
Chairman
David A. Thompson
CEO, Hologic
John W. (Jack) Cumming